% | $
Quotes you view appear here for quick access.

Zogenix, Inc. Message Board

  • speed_racer_razmataz speed_racer_razmataz Oct 28, 2013 4:28 PM Flag

    LOAD UP on ALL DIPS ---- GAP will fill at $5.53 !!!!!!!!!!!!!!!!! see 3 year chart


    William Blair: 1 percent penetration on very conservative numbers = $245 million product revenue flow

    The specialty pharmaceutical company said on Friday that the U.S. Food and Drug Administration approved its drug for treating pain severe enough to require around-the-clock, long-term treatment.

    William Blair analyst Tim Lugo raised his price target on the company's stock to $6 from $3, saying that the drug had a substantial opportunity in the market for chronic pain drugs.

    "If we assume a relatively conservative $7 per day and an average 25 days of therapy, only a 1 percent penetration into the combination market would suggest a $245 million product," he wrote in a note to clients.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
18.41+1.35(+7.91%)Aug 28 4:00 PMEDT